<qa>  What is a non-invasive method to assess liver fibrosis and cirrAll potential participants will be sent written information detailing the study and inviting them to take part. This is to avoid any possible selection bias. The investigators aim to follow up this group for 2 years to collect data on outcomes including reinfection rates using annual HCV RNA with subsequent genotyping if positive and liver disease progression using standard liver function blood tests and a fibroscan a non-invasive method to assess liver fibrosis and cirrhosis. 